Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.

by Thierry Van Effelterre, Gaël Dos Santos, Vivek Shinde
Published 2016-01-01

Estimates of hospitalization attributable to influenza and RSV in the US during 1997–2009, by age and risk status

by Gonçalo Matias, Robert Taylor, François Haguinet, Cynthia Schuck-Paim, Roger Lustig, Vivek Shinde
Published 2017-03-01

Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™ and Narcolepsy.

by Kaatje Bollaerts, Vivek Shinde, Gaël Dos Santos, Germano Ferreira, Vincent Bauchau, Catherine Cohet, Thomas Verstraeten
Published 2016-01-01

The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review.

by Ann D Colosia, Jin Yang, Eric Hillson, Josephine Mauskopf, Catherine Copley-Merriman, Vivek Shinde, Jeffrey Stoddard
Published 2017-01-01

Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome.

by Wanna Hanshaoworakul, James Mark Simmerman, Ubolrat Narueponjirakul, Wiwan Sanasuttipun, Vivek Shinde, Suchada Kaewchana, Darin Areechokechai, Jens Levy, Kumnuan Ungchusak
Published 2009-01-01

A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006.

by Vivek Shinde, Wanna Hanshaoworakul, James M Simmerman, Ubolrat Narueponjirakul, Wiwan Sanasuttipun, Suchada Kaewchana, Darin Areechokechai, Kumnuan Ungchusak, Alicia M Fry
Published 2011-01-01

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

by Alyse D. Portnoff, Nita Patel, Michael J. Massare, Haixia Zhou, Jing-Hui Tian, Bin Zhou, Vivek Shinde, Gregory M. Glenn, Gale Smith
Published 2020-02-01

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

by Louis Fries, Vivek Shinde, Jeffrey J. Stoddard, D. Nigel Thomas, Eloi Kpamegan, Hanxin Lu, Gale Smith, Somia P. Hickman, Pedro Piedra, Gregory M. Glenn
Published 2017-04-01

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adul...

by Melissa K. Andrew, Vivek Shinde, Todd Hatchette, Ardith Ambrose, Guy Boivin, William Bowie, Ayman Chit, Gael Dos Santos, May ElSherif, Karen Green, François Haguinet, Scott A. Halperin, Barbara Ibarguchi, Jennie Johnstone, Kevin Katz, Joanne M. Langley, Jason LeBlanc, Mark Loeb, Donna MacKinnon-Cameron, Anne McCarthy, Janet McElhaney, Allison McGeer, Michaela K. Nichols, Jeff Powis, David Richardson, Makeda Semret, Grant Stiver, Sylvie Trottier, Louis Valiquette, Duncan Webster, Lingyun Ye, Shelly A. McNeil, on behalf of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN)
Published 2017-12-01

Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.

by Maria D Van Kerkhove, Katelijn A H Vandemaele, Vivek Shinde, Giovanna Jaramillo-Gutierrez, Artemis Koukounari, Christl A Donnelly, Luis O Carlino, Rhonda Owen, Beverly Paterson, Louise Pelletier, Julie Vachon, Claudia Gonzalez, Yu Hongjie, Feng Zijian, Shuk Kwan Chuang, Albert Au, Silke Buda, Gerard Krause, Walter Haas, Isabelle Bonmarin, Kiyosu Taniguichi, Kensuke Nakajima, Tokuaki Shobayashi, Yoshihiro Takayama, Tomi Sunagawa, Jean Michel Heraud, Arnaud Orelle, Ethel Palacios, Marianne A B van der Sande, C C H Lieke Wielders, Darren Hunt, Jeffrey Cutter, Vernon J Lee, Juno Thomas, Patricia Santa-Olalla, Maria J Sierra-Moros, Wanna Hanshaoworakul, Kumnuan Ungchusak, Richard Pebody, Seema Jain, Anthony W Mounts, WHO Working Group for Risk Factors for Severe H1N1pdm Infection
Published 2011-07-01